New Biotech Startups Poised To Transform Pet Healthcare

By Kristi Fender

About five years ago, Professor Allan Bradley, FRS, was wrapping up his work building the best-in-class genetically engineered mouse for producing human antibodies. His company, Kymab, would go on to be acquired by Sanofi, and Kymab’s assets were well on their way to becoming successful, life-changing therapies for people.